|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
264,900,000 |
Market
Cap: |
8.27(B) |
Last
Volume: |
49,305,461 |
Avg
Vol: |
7,165,494 |
52
Week Range: |
$12.46 - $31.23 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 606 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile ImmunoGen is a clinical-stage biotechnology company focused on developing the antibody-drug conjugates (ADCs). Co.'s main program is mirvetuximab, an ADC targeting folate receptor alpha, a cell-surface protein overexpressed in a number of epithelial tumors, including ovarian, endometrial, and non-small-cell lung cancers. Pivekimab sunirine is an ADC comprised of an antibody designed to target CD123 with site-specific conjugation to a DNA-alkylating payload of the IGN (indolinobenzodiazepine pseudodimer) class. Co.'s pipeline program, IMGC936, is an ADC that is designed to target ADAM9, an enzyme overexpressed in a range of solid tumors and implicated in tumor progression and metastasis.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
233,563 |
4,785,085 |
4,785,085 |
Total Sell Value |
$0 |
$6,909,682 |
$86,338,289 |
$86,338,289 |
Total People Sold |
0 |
4 |
5 |
5 |
Total Sell Transactions |
0 |
6 |
26 |
26 |
End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Junius Daniel M |
Chief Executive Officer |
|
2013-12-26 |
4 |
OE |
$5.74 |
$41,902 |
D/D |
7,300 |
80,636 |
|
- |
|
Junius Daniel M |
Chief Executive Officer |
|
2013-12-10 |
4 |
S |
$15.11 |
$226,695 |
D/D |
(15,000) |
73,336 |
|
- |
|
Junius Daniel M |
Chief Executive Officer |
|
2013-12-10 |
4 |
OE |
$5.74 |
$86,100 |
D/D |
15,000 |
88,336 |
|
- |
|
Lambert John |
Executive Vice President |
|
2013-12-02 |
4 |
AS |
$14.70 |
$64,317 |
D/D |
(4,375) |
106,857 |
|
- |
|
Lambert John |
Executive Vice President |
|
2013-12-02 |
4 |
OE |
$6.27 |
$27,431 |
D/D |
4,375 |
111,232 |
|
- |
|
Morris Charles Q |
Executive VP & CDO |
|
2013-11-26 |
4 |
AS |
$13.75 |
$171,863 |
D/D |
(12,500) |
37,500 |
|
- |
|
Lambert John |
Executive Vice President |
|
2013-11-01 |
4 |
AS |
$16.41 |
$71,803 |
D/D |
(4,375) |
106,857 |
|
- |
|
Lambert John |
Executive Vice President |
|
2013-11-01 |
4 |
OE |
$6.27 |
$27,431 |
D/D |
4,375 |
111,232 |
|
- |
|
Lambert John |
Executive Vice President |
|
2013-10-01 |
4 |
AS |
$17.07 |
$74,681 |
D/D |
(4,375) |
106,857 |
|
- |
|
Lambert John |
Executive Vice President |
|
2013-10-01 |
4 |
OE |
$6.27 |
$27,431 |
D/D |
4,375 |
111,232 |
|
- |
|
Perry Gregory D |
Chief Financial Officer |
|
2013-09-10 |
4 |
AS |
$17.82 |
$326,692 |
D/D |
(18,337) |
0 |
|
- |
|
Perry Gregory D |
Chief Financial Officer |
|
2013-09-10 |
4 |
OE |
$4.32 |
$79,216 |
D/D |
18,337 |
18,337 |
|
- |
|
Lambert John |
Executive Vice President |
|
2013-09-03 |
4 |
AS |
$16.45 |
$71,982 |
D/D |
(4,375) |
106,857 |
|
- |
|
Lambert John |
Executive Vice President |
|
2013-09-03 |
4 |
OE |
$6.27 |
$27,431 |
D/D |
4,375 |
111,232 |
|
- |
|
Junius Daniel M |
Chief Executive Officer |
|
2013-09-03 |
4 |
AS |
$16.43 |
$273,772 |
D/D |
(16,667) |
73,336 |
|
- |
|
Junius Daniel M |
Chief Executive Officer |
|
2013-09-03 |
4 |
OE |
$5.74 |
$95,669 |
D/D |
16,667 |
90,003 |
|
- |
|
Junius Daniel M |
Chief Executive Officer |
|
2013-08-01 |
4 |
AS |
$19.21 |
$320,140 |
D/D |
(16,667) |
73,336 |
|
- |
|
Junius Daniel M |
Chief Executive Officer |
|
2013-08-01 |
4 |
OE |
$5.74 |
$95,669 |
D/D |
16,667 |
90,003 |
|
- |
|
Lambert John |
Executive Vice President |
|
2013-08-01 |
4 |
AS |
$19.21 |
$84,039 |
D/D |
(4,375) |
106,857 |
|
- |
|
Lambert John |
Executive Vice President |
|
2013-08-01 |
4 |
OE |
$6.27 |
$27,431 |
D/D |
4,375 |
111,232 |
|
- |
|
Oleary James J |
Vice President |
|
2013-07-11 |
4 |
AS |
$19.02 |
$665,630 |
D/D |
(35,000) |
0 |
|
- |
|
Oleary James J |
Vice President |
|
2013-07-11 |
4 |
OE |
$4.12 |
$144,200 |
D/D |
35,000 |
35,000 |
|
- |
|
Junius Daniel M |
Chief Executive Officer |
|
2013-07-03 |
4 |
AS |
$17.31 |
$288,529 |
D/D |
(16,667) |
73,336 |
|
- |
|
Junius Daniel M |
Chief Executive Officer |
|
2013-07-03 |
4 |
OE |
$5.74 |
$95,669 |
D/D |
16,667 |
90,003 |
|
- |
|
Lambert John |
Executive Vice President |
|
2013-07-01 |
4 |
AS |
$16.80 |
$73,500 |
D/D |
(4,375) |
106,857 |
|
- |
|
453 Records found
|
|
Page 12 of 19 |
|
|